Dr. Lal Pathlabs Ltd. Investor Presentation

Dr. Lal Pathlabs Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter
All Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Dr. Lal Pathlabs Ltd.
03 Feb 2020
2793.60
0.88%
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Please find attached a copy of Company's Q3 & 9M FY20 Earnings Presentation, which the Company proposes to share with Analysts / Investors with respect to its Unaudited Financial Results (Standalone and Consolidated) for the Quarter & Nine months ended December 31, 2019, approved by the Board of Directors in their meeting held on February 3, 2020. We request you to please take the same on record.
pdf
logo
Dr. Lal Pathlabs Ltd.
13 Nov 2019
2793.60
0.88%
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Dear Sir/Madam, Dear Sir, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations'), please find attached herewith Corporate Presentation of the Company for Q2 FY 20, which the Company proposes to share with analysts/investors. We request you to please take the same on record. Thanking You,
pdf
logo
Dr. Lal Pathlabs Ltd.
08 Nov 2019
2793.60
0.88%
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Dear Sir/Madam, Please find attached a copy of Company's Q2 & H1 FY20 Earnings Presentation, which the Company proposes to share with Analysts / Investors with respect to its Unaudited Financial Results (Standalone and Consolidated) for the Quarter & Half Year ended September 30, 2019, approved by the Board of Directors in their meeting held on November 8, 2019. We request you to please take the same on record.
pdf
logo
Dr. Lal Pathlabs Ltd.
19 Aug 2019
2793.60
0.88%
pdf
logo
Dr. Lal Pathlabs Ltd.
13 Aug 2019
2793.60
0.88%
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Dear Sir/Madam, Please find attached a copy of Company''s Q1 FY20 Earnings Presentation, which the Company proposes to share with Analysts / Investors with respect to its Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2019, approved by the Board of Directors in their meeting held on August 13, 2019. We request you to please take the same on record.
pdf
logo
Dr. Lal Pathlabs Ltd.
23 May 2019
2793.60
0.88%
pdf
logo
Dr. Lal Pathlabs Ltd.
17 May 2019
2793.60
0.88%
pdf
logo
Dr. Lal Pathlabs Ltd.
15 Feb 2019
2793.60
0.88%
pdf
logo
Dr. Lal Pathlabs Ltd.
08 Feb 2019
2793.60
0.88%
pdf
logo
Dr. Lal Pathlabs Ltd.
12 Nov 2018
2793.60
0.88%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Regulations'), please find attached herewith Corporate Presentation of the Company for Q2 H1 FY19. The aforesaid presentation will also be available on the Company's website- www.lalpathlabs.com. We request you to please take the same on record.
pdf